CAPR - Financial Reports List - Capricor Therapeutics, Inc. - IntrinsicAlpha

Capricor Therapeutics, Inc. CAPR

Healthcare - Biotechnology - NASDAQ - US

$ 9.18

1.32 %

$ 417 M

Market Cap

-7.98

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-7.92%	-833.83%	-624.15%
Annual Report	FY	10-K	2024-12-31	-11.55%	-81.57%	-76.78%
Quarterly Report	Q3	8-K	2024-09-30	-63.44%	-96.49%	-89.52%
Quarterly Report	Q2	8-K	2024-06-30	1.38%	-49.32%	-49.62%
Quarterly Report	Q1	8-K	2024-03-31	64.29%	-2.40%	-25.43%
Quarterly Report	Q4	8-K	2023-12-31	1162.66%	90.26%	86.82%
Annual Report	FY	10-K	2023-12-31	887.79%	23.20%	18.92%
Quarterly Report	Q3	8-K	2023-09-30	288.66%	-2.01%	-5.97%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-6.81%	-5.81%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	5336.28%	-4.51%

1